Board MeetingOutcome of Board Meeting
Neuland Labs' board approved audited FY26 consolidated results: Revenue at ₹2,022.98 Cr, PAT at ₹363.99 Cr.
Neuland Laboratories LimitedNEULANDLAB · Filed with the exchange
It proposed a ₹34/share final dividend and plans a ₹143.4 Cr capacity expansion at Unit 1 for demand growth.
Dr. Mauricio Futran was also appointed to the board.
No comments yet. Be the first.